3-CHLORO-N-(2-HYDROXY-ETHYL)-BENZAMIDE
|
- $160 - $700
- Product name: 3-CHLORO-N-(2-HYDROXY-ETHYL)-BENZAMIDE
- CAS: 57728-64-0
- MF: C9H10ClNO2
- MW: 199.63
- EINECS:
- MDL Number:MFCD00466252
- Synonyms:3-CHLORO-N-(2-HYDROXY-ETHYL)-BENZAMIDE;3-CHLORO-N-(2-HYDROXYETHYL)BENZENECARBOXAMIDE;Benzamide, 3-chloro-N-(2-hydroxyethyl)-
5 prices
Selected condition：
Brand
- Apolloscientific
- Crysdot
- Matrix Scientific
Package
- 0.500g
- 1g
- 5g
- ManufacturerApolloscientific
- Product numberOR957108
- Product description3-Chloro-N-(2-hydroxyethyl)benzamide
- Packaging1g
- Price$304
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12059236
- Product description3-Chloro-N-(2-hydroxyethyl)benzamide 97%
- Packaging5g
- Price$527
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number156844
- Product description3-Chloro-N-(2-hydroxyethyl)benzamide
- Packaging5g
- Price$700
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number156844
- Product description3-Chloro-N-(2-hydroxyethyl)benzamide
- Packaging1g
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number156844
- Product description3-Chloro-N-(2-hydroxyethyl)benzamide
- Packaging0.500g
- Price$160
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Apolloscientific | OR957108 | 3-Chloro-N-(2-hydroxyethyl)benzamide | 1g | $304 | 2021-12-16 | Buy |
| Crysdot | CD12059236 | 3-Chloro-N-(2-hydroxyethyl)benzamide 97% | 5g | $527 | 2021-12-16 | Buy |
| Matrix Scientific | 156844 | 3-Chloro-N-(2-hydroxyethyl)benzamide | 5g | $700 | 2021-12-16 | Buy |
| Matrix Scientific | 156844 | 3-Chloro-N-(2-hydroxyethyl)benzamide | 1g | $200 | 2021-12-16 | Buy |
| Matrix Scientific | 156844 | 3-Chloro-N-(2-hydroxyethyl)benzamide | 0.500g | $160 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|